Procter & Gamble Hygiene and Health Care · NSE: PGHH · BSE: 500459
Q4 FY21 results · Jan–Mar 2021
Procter & Gamble Hygiene and Health Care reported revenue from operations of ₹759.66 crore (up 15.8% from Q4 FY20) and net profit of ₹98.33 crore (up 7.9% from Q4 FY20) for Q4 FY21 (Jan–Mar 2021), on a standalone basis.
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 759.66 | 656.05 | +15.8% | 1,018.44 | −25.4% |
| Other income | 14.75 | 14.52 | +1.6% | 9.35 | +57.8% |
| Total income | 774.41 | 670.57 | +15.5% | 1,027.79 | −24.7% |
| Profit before tax | 129.23 | 124.87 | +3.5% | 337.71 | −61.7% |
| Net profit for the period | 98.33 | 91.10 | +7.9% | 250.62 | −60.8% |
| EPS, basic (₹) | 30.29 | 28.07 | +7.9% | 77.21 | −60.8% |
| Net margin (%) | 12.9 | 13.9 | 24.6 |
Standalone
- Filed with BSE
- 04 May 2021, 19:54 IST
- Board meeting
- 04 May 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE